Transient myeloproliferative disorder progression and acquired chromosomal abnormalities in children with Down syndrome

被引：4
作者：
Picos Cardenas, Veronica Judith [3 ]
Meza Espinoza, Juan Pablo [2 ]
Garibaldi Covarrubias, Roberto Francisco [4 ]
Barajas Torres, Reyna Lucia [1 ]
Gonzalez Garcia, Juan Ramon [1 ]
机构：
[1] Inst Mexicano Seguro Social, Ctr Invest Biomed Occidente, Div Genet, Guadalajara, Jalisco, Mexico
[2] Univ Autonoma Tamaulipas, Fac Med & Ingn Sistemas Comp Matamoros, Matamoros, Tamaulipas, Mexico
[3] Univ Autonoma Sinaloa, Unidad Invest, Fac Med, Lab Genet Humana, Culiacan, Sinaloa, Mexico
[4] Inst Mexicano Seguro Social, Ctr Med Nacl Occidente, Dept Hematol, UMAE H Pediat, Guadalajara, Jalisco, Mexico
来源：
PEDIATRIC BLOOD & CANCER | 2012年 / 59卷 / 05期
关键词：
ACUTE MYELOID-LEUKEMIA; GATA1; MUTATIONS; NATURAL-HISTORY;
D O I：
10.1002/pbc.24248
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：962 / 963
页数：2
相关论文
共 9 条
  • [1] Natural history of GATA1 mutations in Down syndrome
    Ahmed, M
    Sternberg, A
    Hall, G
    Thomas, A
    Smith, O
    O'Marcaigh, A
    Wynn, R
    Stevens, R
    Addison, M
    King, D
    Stewart, B
    Gibson, B
    Roberts, I
    Vyas, P
    [J]. BLOOD, 2004, 103 (07) : 2480 - 2489
  • [2] Analysis of GATA1 mutations in Down syndrome transient myeloproliferative disorder and myeloid leukemia
    Alford, Kate A.
    Reinhardt, Katarina
    Garnett, Catherine
    Norton, Alice
    Boehmer, Katarina
    von Neuhoff, Christine
    Kolenova, Alexandra
    Marchi, Emanuele
    Klusmann, Jan-Henning
    Roberts, Irene
    Hasle, Henrik
    Reinhardt, Dirk
    Vyas, Paresh
    [J]. BLOOD, 2011, 118 (08) : 2222 - 2238
  • [3] Mutational spectrum at GATA1 provides insights into mutagenesis and leukemogenesis in Down syndrome
    Cabelof, Diane C.
    Patel, Hiral V.
    Chen, Qing
    van Remmen, Holly
    Matherly, Larry H.
    Ge, Yubin
    Taub, Jeffrey W.
    [J]. BLOOD, 2009, 114 (13) : 2753 - 2763
  • [4] Complex karyotype newly defined: the strongest prognostic factor in advanced childhood myelodysplastic syndrome
    Goehring, Gudrun
    Michalova, Kyra
    Beverloo, H. Berna
    Betts, David
    Harbott, Jochen
    Haas, Oskar A.
    Kerndrup, Gitte
    Sainati, Laura
    Bergstraesser, Eva
    Hasle, Henrik
    Stary, Jan
    Trebo, Monika
    van den Heuvel-Eibrink, Marry M.
    Zecca, Marco
    van Wering, Elisabeth R.
    Fischer, Alexandra
    Noellke, Peter
    Strahm, Brigitte
    Locatelli, Franco
    Niemeyer, Charlotte M.
    Schlegelberger, Brigitte
    [J]. BLOOD, 2010, 116 (19) : 3766 - 3769
  • [5] Treatment and prognostic impact of transient leukemia in neonates with Down syndrome
    Klusmann, Jan-Henning
    Creutzig, Ursula
    Zimmermann, Martin
    Dworzak, Michael
    Jorch, Norbert
    Langebrake, Claudia
    Pekrun, Amulf
    Macakova-Reinhardt, Katarina
    Reinhardt, Dirk
    [J]. BLOOD, 2008, 111 (06) : 2991 - 2998
  • [6] A prospective study of the natural history of transient leukemia (TL) in neonates with Down syndrome (DS): Children's Oncology Group (COG) study POG-9481
    Massey, Gita V.
    Zipursky, Alvin
    Chang, Myron N.
    Doyle, John J.
    Nasim, Suhail
    Taub, Jeffrey W.
    Ravindranath, Yaddanapudi
    Dahl, Gary
    Weinstein, Howard J.
    [J]. BLOOD, 2006, 107 (12) : 4606 - 4613
  • [7] Risk factors for early death in neonates with Down syndrome and transient leukaemia
    Muramatsu, Hideki
    Kato, Koji
    Watanabe, Nobuhiro
    Matsumoto, Kimikazu
    Nakamura, Tomohiko
    Horikoshi, Yasuo
    Mimaya, Junichi
    Suzuki, Chizuko
    Hayakawa, Masahiro
    Kojima, Seiji
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2008, 142 (04) : 610 - 615
  • [8] Patients with de novo acute myeloid leukaemia and complex karyotype aberrations show a poor prognosis despite intensive treatment:: a study of 90 patients
    Schoch, C
    Haferlach, T
    Haase, D
    Fonatsch, C
    Löffler, H
    Schlegelberger, B
    Staib, P
    Sauerland, MC
    Heinecke, A
    Büchner, T
    Hiddemann, W
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2001, 112 (01) : 118 - 126
  • [9] Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study
    Slovak, ML
    Kopecky, KJ
    Cassileth, PA
    Harrington, DH
    Theil, KS
    Mohamed, A
    Paietta, E
    Willman, CL
    Head, DR
    Rowe, JM
    Forman, SJ
    Appelbaum, FR
    [J]. BLOOD, 2000, 96 (13) : 4075 - 4083
1